Senti Biosciences Holdings, Inc.

Senti Biosciences Holdings, Inc., listed under ticker DYNS, filed an 8-K current report with the SEC on May 14, 2026. The company traces its origins to Dynamics Special Purpose Corp, a blank-check acquisition vehicle that completed its initial public offering in 2021 with Dynamics Special Purpose Corp Sponsor, LLC serving as sponsor. The SPAC subsequently completed a business combination with Senti Biosciences, a synthetic biology company developing programmable gene circuit technology for cell and gene therapies, placing the merged entity in the biotechnology sector. The 8-K reflects the company's ongoing public reporting obligations as a post-combination operating entity. For full filing history, deal analytics, and real-time SPAC data on DYNS, create a free account at SpacDesk.